We are focused on research support on specialty therapy segments to build premium, commanding brands that stand out as innovative and highly differentiated. The modest performance of the Branded Formulation business this year was on account of portfolio optimization to restore focus on key specialty brands having a potential to be a big brand.

We expanded our portfolio with several new, first-of-its-kind offerings in the Indian market this year. Being a patient-centric organization, our divisions conducted patient and physician awareness programs all over India during the year 2019. These programs not only helped educate patients and doctors in disease prevention, detection and management, but also helped in building the value of Brand Biocon. We are confident that our strategic initiatives in this business will enable us to deliver consistent profitable growth in the foreseeable future.

Scroll to Top